quinidine has been researched along with s 9788 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hill, BT; Hosking, LK | 1 |
Dirson, G; Farinotti, R; Fernandez, C; German-Fattal, M; Gimenez, F; Hindlet, P; Roux, F | 1 |
2 other study(ies) available for quinidine and s 9788
Article | Year |
---|---|
Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
Topics: Cyclosporine; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Flunarizine; Humans; Leukemia, T-Cell; Piperidines; Quinidine; Teniposide; Triazines; Tumor Cells, Cultured; Verapamil; Vinblastine | 1994 |
Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
Topics: Alkynes; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzoxazines; Blood-Brain Barrier; Brain; Cell Line; Cyclopropanes; Cyclosporins; Digoxin; Endothelial Cells; Male; Mice; Mice, Knockout; Oxazines; Piperidines; Quinidine; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Triazines | 2006 |